PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING CARDIOVASCULAR AGING DISEASES

Title:

PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING CARDIOVASCULAR AGING DISEASES

Document Type and Number:

WIPO Patent Application WO/2024/072079

Kind Code:

A1

Abstract:

The present invention relates to a pharmaceutical composition for preventing or treating cardiovascular aging diseases, comprising enavogliflozin as an active ingredient. Enavogliflozin of the present invention exhibits excellent effects in the prevention and treatment of endothelial dysfunction caused by vascular endothelial senescence, and cardiovascular aging diseases related thereto.

More Like This:

WO/2011/132712	NOVEL HYDROXAMIC ACID DERIVATIVE
JP2002537326	INDUSTRIAL APPLICABILITY The use of sulfamate derivatives for the treatment of impulsive dysregulation.

Inventors:

PARK SUN-HWA (KR)
PARK JOON SEOK (KR)
CHOI JI-SOO (KR)
JI HYE YOUNG (KR)
OAK MIN-HO (KR)
KO JU-YOUNG (KR)
SHIWAKOTI SAUGAT (KR)
BIKALPA DHAKAL (KR)

Application Number:

PCT/KR2023/014992

Publication Date:

April 04, 2024

Filing Date:

September 27, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

DAEWOONG PHARMACEUTICAL CO LTD (KR)

International Classes:

A61K31/351; A61P9/00

Attorney, Agent or Firm:

DANA PATENT LAW FIRM (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR PERFORMING COMMUNICATION IN WIRELESS COMMUNICATION SYSTEM AND DEVICE THEREFOR

Next Patent: SIGNAL TRANSMISSION AND RECEPTION METHOD FOR WIRELESS COMMUNICATION, AND DEVICE THEREFOR